GB8623389D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number: GB8623389D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1985-10-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

GB868623389A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-01

Filing date

1986-09-29

Publication date

1986-11-05

1985-10-01 Priority claimed from GB858524135A external-priority patent/GB8524135D0/en

1985-10-07 Priority claimed from GB858524653A external-priority patent/GB8524653D0/en

1985-12-20 Priority claimed from GB858531419A external-priority patent/GB8531419D0/en

1986-02-07 Priority claimed from GB868603097A external-priority patent/GB8603097D0/en

1986-02-28 Priority claimed from GB868605037A external-priority patent/GB8605037D0/en

1986-09-29 Priority to GB8623389A priority Critical patent/GB2181053B/en

1986-09-29 Application filed by Sandoz AG filed Critical Sandoz AG

1986-11-05 Publication of GB8623389D0 publication Critical patent/GB8623389D0/en

1987-04-15 Publication of GB2181053A publication Critical patent/GB2181053A/en

1990-05-23 Publication of GB2181053B publication Critical patent/GB2181053B/en

1990-05-23 Application granted granted Critical

1992-07-10 Priority to CY1622A priority patent/CY1622A/en

2006-09-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GB8623389A 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance Expired - Lifetime GB2181053B (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB8623389A GB2181053B (en)	1985-10-01	1986-09-29	Pharmaceutical formulations with controlled release of the active substance
CY1622A CY1622A (en)	1985-10-01	1992-07-10	Pharmaceutical formulations with controlled release of the active substance

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB858524135A GB8524135D0 (en)	1985-10-01	1985-10-01	Darodipine compositions
GB858524653A GB8524653D0 (en)	1985-10-07	1985-10-07	Pharmaceutical formulations
GB858531419A GB8531419D0 (en)	1985-12-20	1985-12-20	Pindolol compositions
GB868603097A GB8603097D0 (en)	1986-02-07	1986-02-07	Pharmaceutical formulations
GB868605037A GB8605037D0 (en)	1986-02-28	1986-02-28	Oral pharmaceutical compositions
GB8623389A GB2181053B (en)	1985-10-01	1986-09-29	Pharmaceutical formulations with controlled release of the active substance

Publications (3)

Publication Number	Publication Date
GB8623389D0 true GB8623389D0 (en)	1986-11-05
GB2181053A GB2181053A (en)	1987-04-15
GB2181053B GB2181053B (en)	1990-05-23

Family

ID=27546915

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB8623389A Expired - Lifetime GB2181053B (en)	1985-10-01	1986-09-29	Pharmaceutical formulations with controlled release of the active substance

Country Status (2)

Country	Link
CY (1)	CY1622A (en)
GB (1)	GB2181053B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4940556A (en) *	1986-01-30	1990-07-10	Syntex (U.S.A.) Inc.	Method of preparing long acting formulation
EP0266707B1 (en) *	1986-11-03	1992-01-22	Schering Corporation	Sustained release labetalol tablet
YU47044B (en) *	1987-03-11	1994-12-28	LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o.	PROCEDURE FOR OBTAINING HIGH-MOLECULAR HYDROXYPROPYL-METHYLCELLULOSE PROLONGED TABLETS
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
GR1000270B (en) *	1988-09-30	1992-05-12	Alza Corp	Dose for cardiovascular troubles therapy
FR2677886B1 (en) *	1991-06-18	1995-03-31	Adir	MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
EP2441445A1 (en) *	2010-10-14	2012-04-18	Deva Holding Anonim Sirketi	Coating of cetyl myristate and/or cetyl palmitate particles
EP2543364A1 (en) *	2010-10-14	2013-01-09	Deva Holding Anonim Sirketi	Formulations of cetyl myristate and/or cetyl palmitate
EP2441446A1 (en) *	2010-10-14	2012-04-18	Deva Holding Anonim Sirketi	Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617393C2 (en) *	1966-01-06	1982-11-11	&Ccaron;eskoslovenská akademie v&ecaron;d, Praha	Process for the preparation of hydrophilic crosslinked copolymers containing biologically active substances
US4369172A (en) *	1981-12-18	1983-01-18	Forest Laboratories Inc.	Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) *	1982-03-26	1983-06-21	Forest Laboratories, Inc.	Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB2154874B (en) *	1984-02-29	1987-11-04	Sandoz Ltd	Bromoscriptine compositions

1986
- 1986-09-29 GB GB8623389A patent/GB2181053B/en not_active Expired - Lifetime
1992
- 1992-07-10 CY CY1622A patent/CY1622A/en unknown

Also Published As

Publication number	Publication date
CY1622A (en)	1992-07-10
GB2181053B (en)	1990-05-23
GB2181053A (en)	1987-04-15

Publication	Publication Date	Title
GR862727B (en)	1987-03-19	Pharmaceutical preparation
GB2174904B (en)	1989-07-05	Vasculoprotecting pharmaceutical compositions
ZW13587A1 (en)	1989-02-15	Pharmaceutical formulations
GB2171600B (en)	1988-08-10	Pharmaceutical compositions
GB8602625D0 (en)	1986-03-12	Pharmaceutical compositions
EP0197752A3 (en)	1988-03-02	Pharmaceutical compositions
GB8515170D0 (en)	1985-07-17	Pharmaceutical compositions
GB8500310D0 (en)	1985-02-13	Pharmaceutical preparation
GB8602602D0 (en)	1986-03-12	Pharmaceutical compositions
GB8623389D0 (en)	1986-11-05	Pharmaceutical formulations
GB8607848D0 (en)	1986-04-30	Pharmaceutical compositions
GB2182561B (en)	1989-12-06	Pharmaceutical compositions
GB8523531D0 (en)	1985-10-30	Pharmaceutical compositions
GB8602601D0 (en)	1986-03-12	Pharmaceutical compositions
GB8522327D0 (en)	1985-10-16	Pharmaceutical compositions
GB8503221D0 (en)	1985-03-13	Pharmaceutical formulations
GR871915B (en)	1988-04-05	Pharmaceutical formulations
GB8502887D0 (en)	1985-03-06	Pharmaceutical compositions
GB8521863D0 (en)	1985-10-09	Pharmaceutical formulations
GB8524653D0 (en)	1985-11-13	Pharmaceutical formulations
GB8502917D0 (en)	1985-03-06	Pharmaceutical formulation
GB8530794D0 (en)	1986-01-22	Pharmaceutical formulation
GB8524811D0 (en)	1985-11-13	Pharmaceutical formulation
GB8519741D0 (en)	1985-09-11	Pharmaceutical formulation
GB8421741D0 (en)	1984-10-03	Pharmaceutical formulations

Legal Events

Date	Code	Title	Description
1997-06-25	732E	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
2006-10-18	PE20	Patent expired after termination of 20 years	Effective date: 20060928